title: Angiotensin System Inhibitors in Renal Cell Carcinoma--Letter.
authors.affiliation: Department of Medical Oncology, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France. olivier.huillard@aphp.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Huillard
authors.affiliation: Department of Urology, Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France.
authors.forename: Evanguelos
authors.initials: E
authors.lastname: Xylinas
authors.affiliation: Department of Urology, Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France.
authors.forename: Michael
authors.initials: M
authors.lastname: Peyromaure
authors.affiliation: Department of Medical Oncology, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France.
authors.forename: Jerome
authors.initials: J
authors.lastname: Alexandre
authors.affiliation: Department of Medical Oncology, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Hopital Cochin, AP-HP, Université Paris Descartes, Paris, France.
authors.forename: Francois
authors.initials: F
authors.lastname: Goldwasser
mesh_terms: D000809:Angiotensins / Q000037:antagonists & inhibitors*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000809:Angiotensins